Ouvrages publiés en collaboration (1)
  1. 1. Van Houtte, P., Charlier, F., Moretti, L., & Van Gestel, D. (2020). Radiotherapy an Alternative to Surgery. doi:10.5772/intechopen.94486
    2.   Articles dans des revues avec comité de lecture (75)
  2. 1. Bouchart, C., Azurmendi Senar, O., Navez, J., Verset, L., Boisson, A., Hein, M., Stosic, K., Quertinmont, E., Tafciu, V., Zhao, S., Mas, L., D'Haene, N., Van Gestel, D., Moretti, L., Michiels, E., Rooman, I., Detours, V., Bachet, J.-B., Demetter, P., Willard-Gallo, K., Nicolle, R., Arsenijevic, T., & Van Laethem, J.-L. (2026). Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy. British Journal of Cancer. doi:10.1038/s41416-025-03274-0
  3. 2. Mootassim-Billah, S., Schoentgen, J., De Bodt, M. M., Slama, H., Willemse, E., Dragan, T., Roper, N., Le Tensorer, M., Kristanto, P., Paesmans, M., Van Gestel, D., & Van Nuffelen, G. (2025). Acoustic Features of Airway Protective Maneuvers as Biomarkers of Radiation-Associated Dysphagia and Penetration/Aspiration in Head and Neck Cancer Patients. Head and Neck, 47(9), 2464-2485.
  4. 3. Sant’Angelo, D., Descamps, G., Lecomte, V., Stanicki, D., Penninckx, S., Dragan, T., Van Gestel, D., Laurent, S., & Journe, F. (2025). Therapeutic Approaches with Iron Oxide Nanoparticles to Induce Ferroptosis and Overcome Radioresistance in Cancers. Pharmaceuticals, 18(3), 325. doi:10.3390/ph18030325
  5. 4. de Bakker, T., Maes, A., Dragan, T., Martinive, P., Penninckx, S., & Van Gestel, D. (2025). Strategies to Overcome Intrinsic and Acquired Resistance to Chemoradiotherapy in Head and Neck Cancer. Cells, 14(1), 18. doi:10.3390/cells14010018
  6. 5. Dragan, T., Soussy, K., Beauvois, S., Lefebvre, Y., Lemort, M., Ozalp, E., Gulyban, A., Burghelea, M., Wardi, C. A., Marin, C., Benkhaled, S., & Van Gestel, D. (2024). Enhanced head and neck radiotherapy target definition through multidisciplinary delineation and peer review: A prospective single-center study. Clinical and Translational Radiation Oncology, 48, 100837. doi:10.1016/j.ctro.2024.100837
  7. 6. Schoenauen, L., Stubbe, F. X., Van Gestel, D., Penninckx, S., & Heuskin, A.-C. (2024). C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect. Clinical and Translational Radiation Oncology, 45, 100712. doi:10.1016/j.ctro.2023.100712
  8. 7. De Caluwe, A., Romano, E., Poortmans, P., Gombos, A., Agostinetto, E., Marta, G. N., Denis, Z., Drisis, S., Vandekerkhove, C., Desmet, A., Philippson, C., Craciun, L., Veys, I., Larsimont, D., Paesmans, M., Van Gestel, D., Salgado, R., Sotiriou, C., Piccart-Gebhart, M., Ignatiadis, M., & Buisseret, L. (2023). First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial. Journal for ImmunoTherapy of Cancer, 11(12). doi:10.1136/jitc-2023-007279
  9. 8. Mootassim-Billah, S., Van Nuffelen, G., Schoentgen, J., De Bodt, M. M., & Van Gestel, D. (2023). Assessment of radio(chemo)therapy‑related dysphagia in head and neck cancer patients based on cough‑related acoustic features: a prospective phase II national clinical trial (ACCOUGH‑P/A trial). Trials.
  10. 9. Burghelea, M., Bakkali Tahiri, J., Dhont, J., Kyndt, M., Gulyban, A., Szkitsak, J., Bogaert, E., Van Gestel, D., & Reynaert, N. (2023). Results of a multicenter 4D computed tomography quality assurance audit: Evaluating image accuracy and consistency. Physics and Imaging in Radiation Oncology, 28, 100479. doi:10.1016/j.phro.2023.100479
  11. 10. Van Houtte, P., & Van Gestel, D. (2023). A quality assurance program: a clear necessity in modern oncology care. Precision cancer medicine, 6, 7921. doi:10.21037/pcm-23-14
  12. 11. Sabbah, M., Najem, A., Vanderkerkhove, C., Kert, F., Jourani, Y., Journe, F., Awada, A., Van Gestel, D., Ghanem, G. E., & Krayem, M. (2023). The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma. Frontiers in medicine, 10. doi:10.3389/fmed.2023.1149918
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>